Quarterly Updates20 May 2026, 06:41 pm
IOL Chemicals: FY26 Revenue Up 11.5% to ₹2319.1 Cr
AI Summary
IOL Chemicals & Pharmaceuticals Ltd. announced its FY26 results, reporting its highest-ever quarterly revenue. Revenue from operations for FY26 stood at ₹2319.1 Cr, an 11.5% increase YoY. EBITDA for FY26 was ₹290.4 Cr, up 29.3% YoY, with an EBITDA margin of 12.4%. PAT for FY26 reached ₹137.7 Cr, a 36.4% increase YoY. The company incurred capex of around ₹164 crore towards capacity expansion and other improvements.
Key Highlights
- Q4 FY26 revenue from operations increased by 17.4% YoY to ₹619.5 Cr.
- Q4 FY26 EBITDA grew by 39.8% YoY to ₹94.3 Cr, with a margin of 15.2%.
- Q4 FY26 PAT increased by 68.2% YoY to ₹53.2 Cr, with a margin of 8.6%.
- FY26 EBITDA margin expanded by 172 bps to 12.4%.
- Company invested ₹164 Cr in capacity expansion and infrastructure development.
Price Impact
More from IOLCP